How can I tell if an online compounded semaglutide pharmacy is FDA compliant?

Short answer: the FDA does not “approve” most compounded drugs, so you can’t verify an online compounder the same way you’d verify a manufacturer of a brand‑name drug. Instead you check a combination of licensure, facility type (503A vs 503B), third‑party accreditations, documentation (COAs, sterility testing), and safe practices. Below is a practical checklist and where to look.

Key background (very briefly)

• 503A compounding pharmacies are state‑licensed and make patient‑specific prescriptions; they’re regulated primarily by state boards of pharmacy and must follow USP compounding standards.
• 503B “outsourcing facilities” must register with the FDA, follow cGMP and are inspected by FDA. FDA maintains a searchable Outsourcing Facility Registry.
• The FDA issues safety communications about compounded versions of approved drugs (including semaglutide); compounded semaglutide is not FDA‑approved.

Checklist to determine whether an online compounded semaglutide pharmacy is likely compliant/safe

1. Require a valid prescription

• The pharmacy should require a prescription from a US‑licensed prescriber (and ideally offer a clinical review or telehealth consult). Any seller that offers injectable semaglutide without a prescription is a red flag.

1. Check state pharmacy license

• Ask for the pharmacy’s state pharmacy license number and verify it on that state’s Board of Pharmacy website. If they’re not licensed in the US state they claim, don’t use them.

1. Is it a 503B outsourcing facility?

• If the pharmacy claims “outsourcing” or large batch production, check the FDA Outsourcing Facility Registry (searchable on FDA.gov) to confirm current registration and inspection status. 503B status is a strong positive signal because the facility must follow FDA cGMP.

1. Look for third‑party accreditation

• Reputable credentials include NABP VIPPS (.pharmacy) and URAC accreditation. These don’t guarantee safety but add credibility. Ask for certificates and confirm with the accreditor’s website.

1. Ask for lab documentation — and review it

• Request a Certificate of Analysis (CoA) for the specific lot showing identity, potency, purity, sterility testing (sterility test), and endotoxin (BET) results. The CoA should have a lab name and lot number that you can verify. Absence of CoAs or generic “we test everything” statements is a red flag.

1. Source of API (active ingredient)

• Ask where the semaglutide API came from. For compounded drugs, the pharmacy should be able to document the supplier and show testing for identity and purity. Note: many bulk peptide suppliers are foreign — that is not automatically disqualifying, but you should see testing and chain‑of‑custody documentation.

1. Sterile compounding standards & personnel

• Because semaglutide is an injectable sterile product, the facility should follow USP <797> sterile compounding standards, have a cleanroom/ISO classified area, and employ trained sterile compounding pharmacists/technicians. Ask about their sterility testing procedures and frequency.

1. Cold‑chain and packaging

• Semaglutide requires refrigerated storage. Confirm their shipping method (cold packs/temperature‑controlled packaging, overnight or two‑day delivery) and how they track temperature excursions.

1. Transparency and contact info

• The site should show a physical US address, a pharmacist license number, a phone number with real pharmacists to speak with, and clear return/adverse‑event reporting policies.

1. Check for FDA actions, recalls, or complaints

• Search the FDA site for the pharmacy name (warning letters, recalls). Also check the state board of pharmacy for disciplinary actions or consumer complaints. Use consumer review sites carefully — many fake reviews exist.

Red flags (don’t use the pharmacy if you see these)

• No prescription required.
• No verifiable US pharmacy license or physical address.
• No COA or vague testing claims.
• “Not for injection” disclaimers or instructions that try to bypass regulation.
• Cheaper than established pharmacies by a wide margin with no explanation.
• Offshore/foreign online pharmacies without US licensing.

Reliable alternatives (brands and services to consider)

• Use FDA‑approved semaglutide medications when possible: Ozempic and Wegovy (both by Novo Nordisk) — regulated, manufactured under cGMP and dispensed through established pharmacies.
• Fill prescriptions at established national pharmacies or mail‑order services you can verify: CVS, Walgreens, Walmart, Costco, OptumRx, Express Scripts. These handle cold‑chain drugs and have pharmacist oversight.
• If a compounded product is truly necessary (e.g., unusual dose or allergy), prefer a 503B outsourcing facility on the FDA Outsourcing Facility Registry or a state‑licensed compounding pharmacy accredited by reputable bodies (NABP/VIPPS or URAC) and affiliated with professional groups such as PCCA (Professional Compounding Centers of America) for recognized compounding training and standards.

Useful resources

• FDA Drug Compounding information and Outsourcing Facility Registry (FDA.gov)
• State Board of Pharmacy lookup (use the board of the state where the pharmacy is located)
• NABP VIPPS/.pharmacy and URAC accreditation directories
• Ask the pharmacy for Certificate of Analysis (CoA), sterility and endotoxin test results, API supplier documentation, and their cold‑chain shipping procedures.

Final practical steps

1. Ask the pharmacy directly for: state license number, 503B status (and FDA registration if they claim it), accreditations, and a recent CoA for the lot you’d receive.
2. Verify each item independently (state board, FDA registry, accreditor website).
3. If anything is missing or they resist providing documentation, do not buy from them — instead obtain an FDA‑approved product via a reputable pharmacy or consult your prescriber about safe options.

If you want, tell me the pharmacy’s name and website and I can help you look up its license, FDA/outsourcing status, and any public enforcement actions.